Advanced search
Publication Cover
Current Eye Research Volume 27, 2003 - Issue 6
Submit an article Journal homepage
31
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit

Eugene W.M. Ng Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
,
Myung-Jin Joo Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
,
Kah-Guan Au Eong Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
,
W. Richard Green Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
&
Terrence P. O’Brien Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Pages 387-393 | Published online: 02 Jul 2009

References

  • Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: A randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995 ;113:1479–1496.
  • Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrec-tomy study. Am J Ophthalmol. 1996;122:830–846.
  • Johnson MW,Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewski SR. The endophthalmitis vitrectomy study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997;104:261–272.
  • Mandelbaum S, Forster RK, Gelender H, Culbertson WW. Late onset endophthalmitis associated with filtering blebs. Ophthalmology. 1985;92:964–972.
  • Hemady R, Zaltas M, Paton B, Foster CS, Baker AS. Bacillus-induced endophthalmitis: New series of 10 cases and review of the literature. Br J Ophthalmol. 1990;74: 26–29.
  • Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Chemotherapy. 1998;44:85–93.
  • Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM1155), trovafloxacin, clinafloxacin, levofloxacin, and cipro-floxacin. J Antimicrob Chemother. 1997;40:639–651.
  • Aldridge KE, Ashcraft D, Bowman KA. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes. Antimicrob Agents Chemother. 1997;41: 484–487.
  • Ednie LM, Jacobs MR, Applebaum PC. Comparative activ-ities of clinafloxacin against gram-positive and -negative bacteria. Antimicrob Agents Chemother. 1998;42:1269–1273.
  • Hoogkamp-Korstanje JAA. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin, and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. J Antimicrob Chemother. 1997;40:427–431.
  • Campochiaro PA, Conway BP. Aminoglycoside toxicity-a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol. 1991;109:946–950.
  • Stevens SX, Fouraker BD, Jensen HG. Intraocular safety of ciprofloxacin. Arch Ophthalmol. 1991;109:1737–1743.
  • Smith MA, D'Aversa G, Sable M et al. Retinal toxicity of intravitreal sparfloxacin, ofloxacin, and imipenem in a rabbit model. J Toxicol-Cut & Ocular Toxicol. 1999; 18:65–73.
  • Cunha BA, Qadri SMI-I, Ueno Y, Walters EA, Domenico P. Antibacterial activity of trovafloxacin against nosocomial gram-positive and gram-negative isolates. J Antimicrob Chemother. 1997;39:29–34.
  • Gfirler B, Ozkul Y, Bitiren M et al. Experimental intravit-real application of trovafloxacin in rabbits. Ophthalmic Res. 2001;33:228–236.
  • Karakucuk S, Mirza E, Sumerkan B, Okten T. Intravitreal trovafloxacin against experimental Staphylococcus epider-midis endophthalmitis. Ophthalmic Res. 2000;32:126–131.
  • Bertino J Jr, Fish D. The safety profile of the fluoro-quinolones. Clin Ther. 2000;22:798–817.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.